Search This Blog

Pages

Thursday, 26 September 2019

Cashing in on dementia patients: drugmaker to pay $116 million in fraud settlement

A pharmaceutical company that whistleblowers alleged paid doctors to prescribe its main drug and urged salespeople to push it as a way to control unruly dementia patients will pay more than $100 million to settle government fraud allegations.

from CNN.com - RSS Channel - App International Edition https://ift.tt/2logTsS

No comments:

Post a Comment

French broadcaster hits back at Bath's TMO criticism

French television broadcaster says the "video referee is the master of what he wants to see" in response to Bath boss Johann van G...